a b c d e f g h i j k l m n o p q r s t u v w x y z
Autism Research Institute
Autism Research Review International
1987 to 2006, Volumes 1 to 20
V
Vaccine Adverse Event Reporting System (VAERS), 2000, Vol. 14(1) pp. 3; 2001, Vol. 15(2) pp. 3; 2002, Vol. 16(3) pp. 3; 2003, Vol. 17(2) pp. 1; 2004, Vol. 18(2) pp. 6; 2006, Vol. 20(1) pp. 1.
Vaccine Guide ( Neustaedter), 1999, Vol. 13(2) pp. 3
Vaccine Information Letter (ARI publication), 2003, Vol. 17(2) pp. 4
Vaccine Injury Compensation Program, 2003, Vol. 17(2) pp. 2; 2004, Vol. 18(4) pp. 3.
vaccine injury lawsuits, 2004, Vol. 18(3) pp. 6
Vaccine Safety Committee of the Institute of Medicine, 2002, Vol. 16(2) pp. 1
Vaccine Safety Datalink (VSD), 2002, Vol. 16(2) pp. 7; 2003, Vol. 17(2) pp. 2; 2003, Vol. 17(4) pp. 7.
Vaccine Victims: A Guide to Bringing Your Vaccine Injury (Styka), 2004, Vol. 18(3) pp. 6
vaccines
""without aborted fetal cell lines, 2003, Vol. 17(3) pp. 7
American Academy of Pediatrics on, 2002, Vol. 16(3) pp. 3
and anaphylaxis, 1995, Vol. 09(1) pp. 1
apnea from, 1999, Vol. 13(3) pp. 1
ARI-sponsored debate on, 2006, Vol. 20(4) pp. 3
attenuated strains, 2000, Vol. 14(4) pp. 2
and autism increase, 1995, Vol. 09(3) pp. 3; 1996, Vol. 10(1) pp. 3; 1996, Vol. 10(4) pp. 1; 2006, Vol. 20(1) pp. 2.
autistics' reactions to, 2001, Vol. 15(4) pp. 7; 2003, Vol. 17(2) pp. 6; 2004, Vol. 18(4) pp. 6.
and autoimmune diseases, 1999, Vol. 13(3) pp. 1; 2003, Vol. 17(3) pp. 5; 2004, Vol. 18(2) pp. 5; 2004, Vol. 18(4) pp. 1.
of cattle, 2002, Vol. 16(1) pp. 6
Centers for Disease Control and Prevention, 1995, Vol. 09(1) pp. 1; 1999, Vol. 13(2) pp. 3.
coverup about, 2004, Vol. 18(4) pp. 2
detoxification from, 1999, Vol. 13(1) pp. 7
Dialyzable Leukocyte Extract for, 1989, Vol. 03(4) pp. 1
DPT (diptheria-pertussis-tetanus) or DTP (diptheria-tetanus-pertussis), 1990, Vol. 04(3) pp. 5; 1995, Vol. 09(1) pp. 1; 1996, Vol. 10(1) pp. 3; 1998, Vol. 12(1) pp. 3; 2000, Vol. 14(1) pp. 3.
DPT or DTP, 2003, Vol. 17(1) pp. 1; 2003, Vol. 17(2) pp. 1; 2003, Vol. 17(4) pp. 2.
and epidemic of autism, 2002, Vol. 16(3) pp. 1
five-in-one, 2006, Vol. 20(2) pp. 4
hepatitis, 1999, Vol. 13(3) pp. 1; 2001, Vol. 15(2) pp. 1.
HIB (hepatitis-influenza-bacillus), 1995, Vol. 09(2) pp. 7
Homeland Security Bill, 2002, Vol. 16(4) pp. 3
and immune dysfunction, 1996, Vol. 10(1) pp. 3
information package from ARI, 1995, Vol. 09(2) pp. 7
injections and oral ingestion compared, 2003, Vol. 17(1) pp. 1
killed-virus vaccines, 2003, Vol. 17(2) pp. 1
lawsuits, 1999, Vol. 13(2) pp. 7; 2001, Vol. 15(1) pp. 2; 2001, Vol. 15(3) pp. 2; 2001, Vol. 15(4) pp. 1.
live vaccines, 2003, Vol. 17(2) pp. 1
and lupus, 2003, Vol. 17(3) pp. 5
and mad cow disease, 1999, Vol. 13(2) pp. 3
mandatory vaccinations, 2001, Vol. 15(2) pp. 1; 2001, Vol. 15(3) pp. 3; 2003, Vol. 17(2) pp. 4.
"mercury-free" vaccines, 2004, Vol. 18(3) pp. 2
and methylation, 2004, Vol. 18(1) pp. 1
mineral oil, 2003, Vol. 17(3) pp. 5
MMR (See measles-mumps-rubella)
monovalent (single-dose) availability, 2003, Vol. 17(3) pp. 7
National Childhood Vaccine Injury Act, 1990, Vol. 04(3) pp. 5; 1992, Vol. 06(3) pp. 6.
National Vaccine Information Center, Dissatisfied Parents Together, 1992, Vol. 06(3) pp. 6; 1995, Vol. 09(1) pp. 6; 1995, Vol. 09(2) pp. 7; 1999, Vol. 13(2) pp. 7.
oral ingestion and injections compared, 2003, Vol. 17(1) pp. 1
pertussis vaccine, 1990, Vol. 04(4) pp. 1; 1995, Vol. 09(1) pp. 1.
political developments, 1999, Vol. 13(2) pp. 7; 1999, Vol. 13(3) pp. 1.
Prevnar, 2001, Vol. 15(2) pp. 1
RhoGam, 2003, Vol. 17(1) pp. 7
Rimland's insights into, 2006, Vol. 20(3) pp. 2
risk factors, 2001, Vol. 15(2) pp. 6; 2001, Vol. 15(4) pp. 1.
rotavirus, 1999, Vol. 13(3) pp. 1
rubella, 1991, Vol. 05(4) pp. 2; 1995, Vol. 09(1) pp. 7.
and seizures, 2003, Vol. 17(2) pp. 2
single-dose availability, 2003, Vol. 17(3) pp. 7
supplements for immune system, 1999, Vol. 13(1) pp. 7; 2000, Vol. 14(1) pp. 5; 2001, Vol. 15(2) pp. 3; 2002, Vol. 16(4) pp. 3.
thimerosol ban sought, 2001, Vol. 15(2) pp. 1; 2004, Vol. 18(3) pp. 1.
toxic chemicals in, 2000, Vol. 14(4) pp. 3
triple vaccines, 2000, Vol. 14(4) pp. 1; 2001, Vol. 15(2) pp. 3.
and UK autism increase, 1996, Vol. 10(4) pp. 1; 1999, Vol. 13(2) pp. 3.
Vaccine Information Letter from ARI, 2003, Vol. 17(2) pp. 4
and vasculitis, 2003, Vol. 17(2) pp. 2
waivers, 1995, Vol. 09(1) pp. 1
Vaccines: Are they really safe and effective? (Miller), 1998, Vol. 12(1) pp. 3; 2002, Vol. 16(4) pp. 3.
vaccinesfor prior to, 2003, Vol. 17(2) pp. 5
Vachtsevanos, George, 2001, Vol. 15(2) pp. 7
vagus nerve stimulators, 1997, Vol. 11(4) pp. 2; 2001, Vol. 15(2) pp. 7; 2002, Vol. 16(3) pp. 5.
Valdovinos, Maria G., 2005, Vol. 19(3) pp. 4
Valentine, Sandy, 1993, Vol. 07(3) pp. 6
valerian, 2003, Vol. 17(1) pp. 4
Valicenti-McDermott, Maria, 2006, Vol. 20(2) pp. 2
Valiquette, Guy, 2002, Vol. 16(4) pp. 6
Valium (diazepam), 1991, Vol. 05(1) pp. 3; 1993, Vol. 07(4) pp. 5; 1998, Vol. 12(1) pp. 7.
valproic acid
- for autistics with EEG epileptiform abnormalities, 1994, Vol. 08(2) pp. 7
and ketogenic diet for seizures compared, 2002, Vol. 16(2) pp. 5
prenatal exposure and autism, 1998, Vol. 12(1) pp. 5; 2000, Vol. 14(3) pp. 5.
Van Bellinghen, Marc, 2001, Vol. 15(2) pp. 4
Van Bourgondien, Mary, 1990, Vol. 04(3) pp. 1–2, 6
van Dam, Paula, 1992, Vol. 06(3) pp. 6
Van de Water, Judy, 2005, Vol. 19(1) pp. 4
Van Den Berghe, Georges, 1987, Vol. 01(2) pp. 1; 1996, Vol. 10(2) pp. 4.
Van der Gaag, R-J, 1996, Vol. 10(2) pp. 4
van der Linden, C., 1995, Vol. 09(4) pp. 4
van der Walt, H., 1999, Vol. 13(3) pp. 5
vancomycin, 2000, Vol. 14(3) pp. 2
Vandegrift, Berthajane, 1995, Vol. 09(1) pp. 7
Vanden Borre, R., 1996, Vol. 10(2) pp. 2
VanderKamp, H.A., 1998, Vol. 12(2) pp. 3
Vanhala, R., 2001, Vol. 15(4) pp. 4
Vargas, Diana L., 2004, Vol. 18(4) pp. 1–2
vasculitis, 2003, Vol. 17(2) pp. 2
Vasotec, 1996, Vol. 10(3) pp. 4
Vazquez, Carol, 1994, Vol. 08(1) pp. 7
Veal, Barbara, 1993, Vol. 07(3) pp. 6
Veale, Tina K., 1993, Vol. 07(3) pp. 2
velocardiofacial syndrome, 1999, Vol. 13(1) pp. 6
Venables, Donna. See Donna Williams
Venables, Paul, 1994, Vol. 08(4) pp. 7
venlafaxine (Effexor), 2000, Vol. 14(2) pp. 4; 2003, Vol. 17(3) pp. 2; 2004, Vol. 18(3) pp. 6.
Venn, Martha L., 1996, Vol. 10(2) pp. 5
venous thromboembolism, 2000, Vol. 14(4) pp. 4
Venter, André, 1992, Vol. 06(3) pp. 5
ventricular enlargement, 1987, Vol. 01(4) pp. 6; 1988, Vol. 02(2) pp. 7; 1988, Vol. 02(4) pp. ; 1990, Vol. 04(1) pp. 4.
verbal IQ, 2006, Vol. 20(3) pp. 5
Vere, Duncan, 2000, Vol. 14(4) pp. 1
Verotti, June A., 2005, Vol. 19(4) pp. 4
Versed (midazolam), 1999, Vol. 13(3) pp. 5; 2000, Vol. 14(4) pp. 7.
Verstraeten, Thomas, 2003, Vol. 17(4) pp. 1; 2004, Vol. 18(2) pp. 6.
Verstraeten study, 2003, Vol. 17(4) pp. 7; 2004, Vol. 18(2) pp. 3.
vestibular neural impulse
- exercise to stimulate, 1988, Vol. 02(4) pp. 3
vestibular stimulation, 1987, Vol. 01(3) pp. 3
Via, Charles S., 2003, Vol. 17(3) pp. 5
Vickrey, Barbara, 1996, Vol. 10(3) pp. 5
video modeling, 2003, Vol. 17(1) pp. 5
videotapes
- autistic babies' home videos, 1994, Vol. 08(3) pp. 4; 1999, Vol. 13(1) pp. 1.
Behavioral Treatment of Autistic Children (Lovaas), 1995, Vol. 09(1) pp. 6
on conversation, 1990, Vol. 04(1) pp. 5
on early intervention, 1995, Vol. 09(1) pp. 6
and echolalia, 1996, Vol. 10(3) pp. 6
"It's Potty Time," Duke University Pediatrics Department, 1994, Vol. 08(1) pp. 7
on life-skills, 1987, Vol. 01(1) pp. 5
on sensory integration therapy, 1995, Vol. 09(1) pp. 6
on toilet training, 1994, Vol. 08(1) pp. 7
Vitamin B6 and Magnesium in the Treatment of Autism (ARI), 1994, Vol. 08(3) pp. 6
villus atrophy, 1999, Vol. 13(4) pp. 7
violence
- in Asperger's, 1995, Vol. 09(2) pp. 6
drugs for, 1996, Vol. 10(1) pp. 4; 1996, Vol. 10(3) pp. 2; 1998, Vol. 12(1) pp. 4.
virtual reality, 1997, Vol. 11(1) pp. 5; 2002, Vol. 16(3) pp. 5.
viruses. See infections
Visalli, Hank, 1997, Vol. 11(4) pp. 5
vision problems
- ambient lenses for, 1996, Vol. 10(4) pp. 4
and attention, 1998, Vol. 12(3) pp. 6; 2006, Vol. 20(2) pp. 3.
and behaviors, 1998, Vol. 12(3) pp. 6; 2006, Vol. 20(2) pp. 3.
cod liver oil for vision, 2000, Vol. 14(1) pp. 6
and coordination, 1999, Vol. 13(3) pp. 6
dyslexia, 2000, Vol. 14(4) pp. 6
and gait problems, 1996, Vol. 10(4) pp. 4; 1998, Vol. 12(3) pp. 6.
immersion virtual reality for, 1997, Vol. 11(1) pp. 5
and orientation, 1998, Vol. 12(3) pp. 6
prism lenses for, 1998, Vol. 12(3) pp. 6; 2001, Vol. 15(2) pp. 5.
saccades in autistics, 2004, Vol. 18(3) pp. 4
Scotopic Sensitivity Syndrome, 1995, Vol. 09(4) pp. 6
secretin for, 1998, Vol. 12(3) pp. 4
strabismus, 1999, Vol. 13(3) pp. 6
vision therapy, 1992, Vol. 06(1) pp. 6
visual screening, 1989, Vol. 03(3) pp. 1; 1989, Vol. 03(4) pp. 6.
vitamin A
- birth defects and excess of, 1995, Vol. 09(4) pp. 5
corneal ulcers from deficiency of, 1998, Vol. 12(3) pp. 4
for ear infections, 1994, Vol. 08(4) pp. 1; 2002, Vol. 16(3) pp. 7.
and measles, 2000, Vol. 14(1) pp. 5
vitamin B 1987, Vol. 01(t) pp. ,; 2002, Vol. 16(3) pp. 4.
vitamin B 1989, Vol. 03(n) pp. ,; 1998, Vol. 12(3) pp. 7.
vitamin B6
- and 5-HTP for sleep and behavior, 1999, Vol. 13(1) pp. 2
absorption problems in autistics, 2005, Vol. 19(1) pp. 2; 2006, Vol. 20(1) pp. 1.
for ADHD, 1995, Vol. 09(1) pp. 7; 1998, Vol. 12(2) pp. 4; 2001, Vol. 15(2) pp. 6.
for aggression, 1992, Vol. 06(1) pp. 7; 1992, Vol. 06(2) pp. 6; 1992, Vol. 06(4) pp. 6; 1993, Vol. 07(1) pp. 7; 1993, Vol. 07(3) pp. 1; 1996, Vol. 10(4) pp. 7; 2001, Vol. 15(1) pp. 6; 2001, Vol. 15(4) pp. 3; 2005, Vol. 19(1) pp. 3.
for alertness, 1996, Vol. 10(3) pp. 7
for aluminum toxicity, 2003, Vol. 17(1) pp. 4
for Asperger's, 1995, Vol. 09(1) pp. 7
for attention, 1992, Vol. 06(1) pp. 4; 1993, Vol. 07(1) pp. 7; 1994, Vol. 08(3) pp. 6; 1994, Vol. 08(4) pp. 7; 1996, Vol. 10(3) pp. 7; 2001, Vol. 15(2) pp. 6.
and behavioral problems, 1987, Vol. 01(4) pp. 3; 1988, Vol. 02(4) pp. 2; 1992, Vol. 06(1) pp. 6; 1993, Vol. 07(1) pp. 7; 1993, Vol. 07(4) pp. 6; 1994, Vol. 08(3) pp. 6; 1998, Vol. 12(2) pp. 6; 2000, Vol. 14(3) pp. 3; 2005, Vol. 19(4) pp. 7; 2006, Vol. 20(3) pp. 2.
and cardiac longevity, 1997, Vol. 11(3) pp. 3
for cluminess, 2005, Vol. 19(4) pp. 7
for communication skills, 1993, Vol. 07(1) pp. 7; 1993, Vol. 07(4) pp. 1; 1994, Vol. 08(2) pp. 6.
for comprehension, 1998, Vol. 12(2) pp. 6; 1998, Vol. 12(3) pp. 7.
for concentration, 1992, Vol. 06(1) pp. 7
deficiency diseases, 1995, Vol. 09(3) pp. 3; 1997, Vol. 11(3) pp. 1.
depression and deficiency of, 2004, Vol. 18(4) pp. 4
dosage, 1995, Vol. 09(2) pp. 7; 1997, Vol. 11(4) pp. 3; 1998, Vol. 12(2) pp. 3.
and drugs, 1991, Vol. 05(1) pp. 3; 1992, Vol. 06(2) pp. 2; 1995, Vol. 09(1) pp. 7; 2002, Vol. 16(3) pp. 4.
and early intervention, 1995, Vol. 09(4) pp. 6; 1998, Vol. 12(1) pp. 2.
for eye contact, 1992, Vol. 06(1) pp. 7; 1993, Vol. 07(4) pp. 1; 1995, Vol. 09(2) pp. 7; 2001, Vol. 15(3) pp. 6.
for fixations, 1991, Vol. 05(4) pp. 7
and folic acid, 1987, Vol. 01(1) pp. 6
for Fragile X, 1993, Vol. 07(2) pp. 4
for functional association disorders, 1990, Vol. 04(2) pp. 4
funding needed for research on, 1997, Vol. 11(2) pp. 3
for homocysteine lowering, 2003, Vol. 17(1) pp. 5
for hyperactivity, 2006, Vol. 20(3) pp. 5
and immune system, 1993, Vol. 07(4) pp. 1
for insomnia, 1992, Vol. 06(1) pp. 7; 1994, Vol. 08(2) pp. 6; 1994, Vol. 08(3) pp. 1.
for IQ, 2002, Vol. 16(2) pp. 2
for language, 1990, Vol. 04(4) pp. 7; 1995, Vol. 09(2) pp. 7.
metabolic functions and, 1988, Vol. 02(4) pp. 2
for mood, 1991, Vol. 05(2) pp. 7; 1992, Vol. 06(1) pp. 6; 1993, Vol. 07(1) pp. 7; 1994, Vol. 08(4) pp. 7; 2002, Vol. 16(4) pp. 4.
for motor skills, 1993, Vol. 07(4) pp. 6; 2002, Vol. 16(2) pp. 2.
for mouthing objects, 2005, Vol. 19(4) pp. 7
for neuroleptic malignant syndrome, 1998, Vol. 12(4) pp. 6
and oxidative stress, 2005, Vol. 19(2) pp. 6
for panic attacks, 2001, Vol. 15(1) pp. 6
and peptides, 1992, Vol. 06(1) pp. 7; 1993, Vol. 07(1) pp. 4.
and peripheral neuropathy, 1996, Vol. 10(3) pp. 3
for perseveration, 1992, Vol. 06(1) pp. 7
and phenytoin, 2005, Vol. 19(4) pp. 7
for play, 1992, Vol. 06(1) pp. 7; 1993, Vol. 07(4) pp. 6.
P5P, 2001, Vol. 15(4) pp. 3; 2006, Vol. 20(1) pp. 1; 2006, Vol. 20(2) pp. 6.
pyrodoxine HCl, 2006, Vol. 20(1) pp. 6
pyroluria and deficiency, 1997, Vol. 11(3) pp. 1
Rimland's study protocol, 2000, Vol. 14(3) pp. 3
for ritualistic behaviors, 1991, Vol. 05(4) pp. 7; 1992, Vol. 06(2) pp. 6.
scientific proof of its effectiveness, 1999, Vol. 13(3) pp. 3
for seizures, 1994, Vol. 08(1) pp. 1; 1995, Vol. 09(3) pp. 6; 1995, Vol. 09(4) pp. 3; 1996, Vol. 10(2) pp. 1; 1996, Vol. 10(3) pp. 3; 2005, Vol. 19(1) pp. 3.
for self-injury, 1992, Vol. 06(2) pp. 6; 1994, Vol. 08(4) pp. 7; 2001, Vol. 15(4) pp. 3; 2005, Vol. 19(1) pp. 3.
for self-stimulating behaviors, 1992, Vol. 06(1) pp. 7; 1996, Vol. 10(3) pp. 7.
and serotonin, 1997, Vol. 11(2) pp. 3
for sleep, 1991, Vol. 05(2) pp. 7; 1994, Vol. 08(2) pp. 6; 1994, Vol. 08(3) pp. 2.
for sociability, 1991, Vol. 05(2) pp. 7; 1993, Vol. 07(1) pp. 7; 1994, Vol. 08(2) pp. 6; 1995, Vol. 09(2) pp. 7.
for sound sensitivity, 1992, Vol. 06(4) pp. 6; 1994, Vol. 08(1) pp. 7; 2002, Vol. 16(2) pp. 2; 2006, Vol. 20(3) pp. 5.
for speech, 1993, Vol. 07(3) pp. 6; 1994, Vol. 08(1) pp. 7; 1994, Vol. 08(2) pp. 6; 1996, Vol. 10(2) pp. 1; 1996, Vol. 10(3) pp. 7; 1998, Vol. 12(1) pp. 7; 1998, Vol. 12(3) pp. 7; 2001, Vol. 15(3) pp. 6; 2002, Vol. 16(2) pp. 2.
and sulfation problems in autistics, 2003, Vol. 17(2) pp. 7
for tantrums, 1993, Vol. 07(4) pp. 6; 1994, Vol. 08(3) pp. 2; 2005, Vol. 19(4) pp. 7.
for tardive dyskinesia, 1992, Vol. 06(2) pp. 7; 1999, Vol. 13(3) pp. 2; 2003, Vol. 17(4) pp. 4; 2006, Vol. 20(2) pp. 2.
for verbal IQ, 2006, Vol. 20(3) pp. 5
Vitamin B6 and Magnesium in the Treatment of Autism, (ARI videotape), 1994, Vol. 08(3) pp. 6
vitamin B12, 1997, Vol. 11(3) pp. 3; 2003, Vol. 17(1) pp. 5; 2004, Vol. 18(1) pp. 1; 2004, Vol. 18(3) pp. 3; 2005, Vol. 19(4) pp. 1.
vitamin B1 1991, Vol. 05(2) pp. 3
vitamin C
- and anticonvulsants, 2005, Vol. 19(4) pp. 7
for autistic symptoms, 2001, Vol. 15(3) pp. 6; 2005, Vol. 19(2) pp. 6.
in autistics, 2005, Vol. 19(1) pp. 2
for behaviors, 1992, Vol. 06(1) pp. 4
for cancer, 1998, Vol. 12(2) pp. 3
deficiency and death rate among aboriginal children, 1998, Vol. 12(1) pp. 3; 2000, Vol. 14(1) pp. 5; 2002, Vol. 16(4) pp. 3.
for depression, 1998, Vol. 12(2) pp. 3
dosages, 1997, Vol. 11(4) pp. 3
for ear infections, 1994, Vol. 08(4) pp. 1–2
and fatty acids, 2005, Vol. 19(4) pp. 2
forms of, 1998, Vol. 12(2) pp. 3
and haloperidol, 1988, Vol. 02(3) pp. 4; 1992, Vol. 06(1) pp. 4; 1992, Vol. 06(2) pp. 2.
Linus Pauling's work, 1995, Vol. 09(1) pp. 2; 1997, Vol. 11(4) pp. 3.
and longevity, 1993, Vol. 07(2) pp. 1
neural tube defects and deficiency of, 1989, Vol. 03(2) pp. 4
for psychiatric conditions, 1998, Vol. 12(2) pp. 3
for socialization, 1998, Vol. 12(2) pp. 3
for speech, 2001, Vol. 15(3) pp. 6
for tardive dyskinesia, 1992, Vol. 06(2) pp. 7
for toxic exposure, 1998, Vol. 12(2) pp. 3; 2000, Vol. 14(1) pp. 5.
for vaccination reactions, 2000, Vol. 14(1) pp. 5
vitamin D, 1998, Vol. 12(3) pp. 4; 2004, Vol. 18(3) pp. 4; 2005, Vol. 19(2) pp. 4.
vitamin E
- for ADHD, 2006, Vol. 20(2) pp. 4
and anti-convulsants, 2005, Vol. 19(4) pp. 7
and dopamine system, 1998, Vol. 12(4) pp. 6
and heart disease, 1993, Vol. 07(2) pp. 1
for neuroleptic malignant syndrome, 1998, Vol. 12(4) pp. 6
for tardive dyskinesia, 1991, Vol. 05(1) pp. 5; 1992, Vol. 06(2) pp. 7; 1994, Vol. 08(3) pp. 1; 1996, Vol. 10(2) pp. 5; 1996, Vol. 10(4) pp. 7; 1998, Vol. 12(3) pp. 5; 1998, Vol. 12(4) pp. 6.
vitamin therapy. See supplements, individual entries
vocabulary, 2000, Vol. 14(4) pp. 5; 2001, Vol. 15(3) pp. 6; 2002, Vol. 16(2) pp. 4; 2002, Vol. 16(3) pp. 6.
vocational training. See also employment
- exercise for self-stimulating behaviors, 1997, Vol. 11(2) pp. 5
jobs suitable for autistics, 1989, Vol. 03(1) pp. 6; 1990, Vol. 04(3) pp. 1.
reinforcement techniques, 1987, Vol. 01(1) pp. 5; 1988, Vol. 02(1) pp. 5; 1994, Vol. 08(4) pp. 5.
sensory integration therapy in, 1991, Vol. 05(2) pp. 6
social skills training, 1994, Vol. 08(4) pp. 6; 1999, Vol. 13(4) pp. 5.
task variation and repetition compared, 1998, Vol. 12(4) pp. 5
work arrangements, 1990, Vol. 04(3) pp. 2
workplace difficulties, 1990, Vol. 04(3) pp. 1
Voeltz, L.M., 1990, Vol. 04(1) pp. 5
Voice of the Retarded (VOR), 1991, Vol. 05(4) pp. 6; 1997, Vol. 11(1) pp. 3.
Voices of Safety International (VOSI), 2001, Vol. 15(2) pp. 6; 2003, Vol. 17(2) pp. 5.
Vojdani, Aristo, 2003, Vol. 17(4) pp. 4; 2004, Vol. 18(3) pp. 3; 2006, Vol. 20(3) pp. 7.
volatile organic solvents, 2006, Vol. 20(1) pp. 3
voles, 1992, Vol. 06(3) pp. 4
Volkmar, Fred R., 1987, Vol. 01(3) pp. 4; 1989, Vol. 03(4) pp. 5; 1999, Vol. 13(4) pp. 7; 2000, Vol. 14(1) pp. 7.
Vollmer, Timothy R., 2002, Vol. 16(2) pp. 5
vom Saul, Frederick, 2003, Vol. 17(2) pp. 6
vomiting, 1995, Vol. 09(2) pp. 7; 1995, Vol. 09(3) pp. 6.
von Economo neurons, 2005, Vol. 19(2) pp. 4
VOSI (Voices of Safety International), 2001, Vol. 15(2) pp. 6; 2003, Vol. 17(2) pp. 5.
Vrijheid, Martine, 2002, Vol. 16(1) pp. 4
Vrono, M. S., 1988, Vol. 02(3) pp. 7; 1991, Vol. 05(3) pp. 2.
© 2007-2008 Autism Research Institute | Sitemap | Notices | Webcasts